1. Home
  2. ASBP vs BREA Comparison

ASBP vs BREA Comparison

Compare ASBP & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASBP
  • BREA
  • Stock Information
  • Founded
  • ASBP 2021
  • BREA 2022
  • Country
  • ASBP United States
  • BREA Ireland
  • Employees
  • ASBP N/A
  • BREA N/A
  • Industry
  • ASBP Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • ASBP Health Care
  • BREA Consumer Discretionary
  • Exchange
  • ASBP Nasdaq
  • BREA Nasdaq
  • Market Cap
  • ASBP 11.9M
  • BREA 13.6M
  • IPO Year
  • ASBP N/A
  • BREA 2023
  • Fundamental
  • Price
  • ASBP $0.28
  • BREA $6.88
  • Analyst Decision
  • ASBP
  • BREA
  • Analyst Count
  • ASBP 0
  • BREA 0
  • Target Price
  • ASBP N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • ASBP 4.2M
  • BREA 18.5K
  • Earning Date
  • ASBP 08-24-2025
  • BREA 01-03-2025
  • Dividend Yield
  • ASBP N/A
  • BREA N/A
  • EPS Growth
  • ASBP N/A
  • BREA N/A
  • EPS
  • ASBP N/A
  • BREA N/A
  • Revenue
  • ASBP N/A
  • BREA $2,988,009.00
  • Revenue This Year
  • ASBP N/A
  • BREA N/A
  • Revenue Next Year
  • ASBP N/A
  • BREA N/A
  • P/E Ratio
  • ASBP N/A
  • BREA N/A
  • Revenue Growth
  • ASBP N/A
  • BREA 151.51
  • 52 Week Low
  • ASBP $0.22
  • BREA $5.00
  • 52 Week High
  • ASBP $15.80
  • BREA $19.50
  • Technical
  • Relative Strength Index (RSI)
  • ASBP N/A
  • BREA 96.66
  • Support Level
  • ASBP N/A
  • BREA $0.66
  • Resistance Level
  • ASBP N/A
  • BREA $0.79
  • Average True Range (ATR)
  • ASBP 0.00
  • BREA 0.20
  • MACD
  • ASBP 0.00
  • BREA 0.39
  • Stochastic Oscillator
  • ASBP 0.00
  • BREA 84.50

About ASBP Aspire Biopharma Holdings Inc. Common Stock

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: